semaglutide for chronic kidney disease Novo Nordisk's Ozempic Gets FDA Approval as Kidney-Disease Treatment Effects of Semaglutide on CKD

32 IngkaninanK.PhengpaP.YuenyongsawadS.KhoranaN

Specifically, those starting GLP-1RA had a significantly higher risk of thyroid cancer within the first year of treatment (HR 1.85), compared to those taking other diabetes medications, such as sodium-glucose cotransporter 2 inhibitors (SGLT2i), dipeptidyl peptidase-4 inhibitors (DPP4i), or sulfonylureas

The research was carried out in the laboratory of Stephen Bloom (figure 30), an endocrinologist with a long-standing interest in glucagon as well as obesity and diabetes

Potential side effects from combining Wegovy and alcohol include nausea, vomiting, diarrhea, dizziness, confusion, dehydration, increased heart rate, and anxiety